Story thread · 2 reports / 2 sources
Apnimed scouts $160m IPO to back late-stage sleep apnoea pill development
finance.yahoo.com · 14d
How the coverage leans
Across 2 sources · syndicated copies counted once
First report: Shionogi-Backed Apnimed Seeks to Raise $160 Million in US IPO — bloomberg.com, 15d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.